Scopia Capital Management Portfolio
Scopia Capital Management 13F filer (CIK 0001279150).
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2023 · 32 positions · Total reported value $989.47M · Top-10 concentration 66.0% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 86.4% · 0 new · 16 cut · 3 exited
Active Share (vs S&P 500): 95.9% · vs QQQ: 95.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +17.9% · vs SPY +3.1% · Prev Value $145.80M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2023 13F filing, Scopia Capital Management disclosed 32 equity positions with a combined reported value of $989.47M. The filing implies a focused portfolio: its ten largest positions account for 66.0% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q2 2023 were INDV ($228.26M), RRX ($62.55M), QRVO ($59.20M). By sector, the heaviest allocations are Technology 27.1%, Health Care 23.6%. Versus the prior quarter, allocation shifted toward Health Care (+23.3pp) and away from Miscellaneous (-2.6pp), Technology (-3.2pp).
Versus the prior quarter, Scopia Capital Management opened 0 new positions, trimmed 16 and fully exited 3, a turnover rate of 86.4% of positions. The portfolio's overlap with the prior quarter was 70% of names.
The largest new positions opened in Q2 2023 were INDV ($228.26M), S ($20.11M), AER ($19.53M).
Of the 3 positions fully exited versus the prior quarter, the largest were MDU ($39.14M), AVY ($31.62M), IWM ($30.27M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2023)
- INDV INDIVIOR PHARMACEUTICALS INC · $228.26M
- S SENTINELONE INC · $20.11M
- AER AERCAP HOLDINGS NV · $19.53M
- SMTC SEMTECH CORP · $14.25M
- WRBY WARBY PARKER INC · $2.11M
- CVNA CARVANA CO · $201.45K
Insider Transactions (Form 4)
Latest Scopia Capital Management buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Scopia Capital Management, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 19 positions worth $111.73M in total. HoldingsHub carries 54 quarters of its filings (Q1 2013–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-61668 (status: Approved), registered 2003-01-02
- Regulatory AUM (Form ADV): $587.34M as of 2026-10-01
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 4 private funds, of which 2 hedge funds
- Website: scopia.com
Portfolio Structure
- 19 positions · $111.73M reported value (Q2 2026)
- Top 10 holdings = 74.4% of reported value
- Largest position: VVV (VALVOLINE INC) at 10.0%
- Average position size: $5.88M
Sector Tilt
- Consumer Discretionary 28.1%
- Industrials 26.1%
- Consumer Staples 15.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 added, 16 reduced, 3 exited
- 2 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
9.59M | $228.26M | 23.07% | New | |
| 2 |
|
406.42K | $62.55M | 6.32% | Reduce | |
| 3 |
|
580.22K | $59.20M | 5.98% | Add | |
| 4 |
|
533.97K | $57.95M | 5.86% | Reduce | |
| 5 |
|
3.16M | $51.17M | 5.17% | Reduce | |
| 6 |
|
1.21M | $48.31M | 4.88% | Add | |
| 7 |
|
97.30K | $43.13M | 4.36% | Add | |
| 8 |
|
245.52K | $38.64M | 3.90% | Add | |
| 9 |
|
144.75K | $32.82M | 3.32% | Add | |
| 10 |
|
938.20K | $30.78M | 3.11% | Reduce | |
| 11 |
|
1.09M | $29.16M | 2.95% | Reduce | |
| 12 |
|
1.18M | $28.86M | 2.92% | Add | |
| 13 |
|
3.64M | $28.00M | 2.83% | Add | |
| 14 |
|
635.64K | $27.36M | 2.77% | Reduce | |
| 15 |
|
309.36K | $25.88M | 2.62% | Reduce | |
| 16 |
|
1.46M | $25.66M | 2.59% | Reduce | |
| 17 |
|
356.16K | $23.17M | 2.34% | Reduce | |
| 18 |
|
1.91M | $22.01M | 2.22% | Add | |
| 19 |
|
341.57K | $21.90M | 2.21% | Reduce | |
| 20 |
|
304.67K | $21.08M | 2.13% | Reduce | |
| 21 |
|
1.33M | $20.11M | 2.03% | New | |
| 22 |
|
307.51K | $19.53M | 1.97% | New | |
| 23 |
|
3.29M | $16.01M | 1.62% | Reduce | |
| 24 |
|
559.52K | $14.25M | 1.44% | New | |
| 25 |
|
17.00K | $4.88M | 0.49% | Hold | |
| 26 |
|
694.96K | $2.83M | 0.29% | Hold | |
| 27 |
|
180.50K | $2.11M | 0.21% | New | |
| 28 |
|
98.16K | $1.94M | 0.20% | Reduce | |
| 29 |
|
85.95K | $1.01M | 0.10% | Hold | |
| 30 |
|
11.10K | $490.13K | 0.05% | Hold | |
| 31 |
|
3.05K | $218.32K | 0.02% | Hold | |
| 32 |
|
7.77K | $201.45K | 0.02% | New | |
FAQ
What did Scopia Capital Management buy in 2023-Q2?
In its 2023-Q2 13F filing, Scopia Capital Management reported 32 equity positions worth $989.47M in aggregate; its largest disclosed positions were INDV ($228.26M), RRX ($62.55M), QRVO ($59.20M).
How large is Scopia Capital Management's portfolio?
Scopia Capital Management reported $989.47M of long equity holdings across 32 positions as of 2023-Q2. Top-10 holdings account for 66.0% of reported value.
What is Scopia Capital Management's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.